Skip to main content

Tiziana Life Sciences Ltd

TLSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001723069

In the last 90 days, Tiziana Life Sciences Ltd insiders filed 4 open-market purchases and 0 sales; 30 institutions reported holding it in 13F filings for Q2 2026, worth $3.10M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Tiziana Life Sciences Ltd changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of TLSA: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders3031+1
Shares4.56M4.04M−522.1K (−11.4%)
Value$4.04M$8.72M+$4.68M (+115.8%)

New holders (7)

Institutions that held Tiziana Life Sciences Ltd at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to TLSA in Q3 2025
InstitutionSharesValue% of portfolio
Millennium Management LLC240,814$520.2K0.00%
Quadrature Capital Ltd37,405$80.8K0.00%
ARS Investment Partners, LLC30,700$66.3K0.00%
Goldman Sachs Group Inc21,460$46.4K0.00%
Independent Financial Group, LLC15,845$34.2K0.00%
US Bancorp10,157$21.9K0.00%
Jones Financial Companies LLLP650$1.34K0.00%

Sold out (6)

Institutions that held Tiziana Life Sciences Ltd at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of TLSA in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Citadel Advisors LLC198,990$314.4K
HRT Financial LP84,106$132.0K
Simplex Trading, LLC67,251$106.0K
Armis Advisers, LLC42,795$63.3K
Two Sigma Securities, LLC17,458$27.6K
Raymond James Financial Inc500$790